GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE

Details for Australian Patent Application No. 2002322430 (hide)

Owner EXELIXIS, INC.

Inventors KADYK, Lisa, C.; LI, Danxi; FUNKE, Roel, P.; FRIEDMAN, Lori; PLOWMAN, Gregory, D.

Pub. Number AU-A-2002322430

PCT Number PCT/US02/21694

PCT Pub. Number WO2003/006611

Priority 60/328,507 10.10.01 US; 60/305,016 12.07.01 US

Filing date 10 July 2002

Wipo publication date 29 January 2003

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/328,507 10.10.01 US; 60/305,016 12.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002322430

6 May 2004 Amendment Made

  The nature of the amendment is: Add the co-inventor Roche, Siobhan 2002322527 CV Therapeutics, Inc. The nature of the amendment is as shown in the statement(s) filed 06 Apr 2004

9 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322431-DIRECTIONAL SOUND ACQUISITION

2002322429-USE OF MATRIX METALLOPROTEINASE INHIBITORS TO MITIGATE NERVE DAMAGE